Position in BCRX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$18,262,340
+$886,589 QoQ
Shares Held
1,826,234
+0.1% QoQ
Ownership
0.715%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#36
of 316 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026STIFEL FINANCIAL CORP holds $141,737,028 across 29 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (12.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
2,604,559 | $24,300,533 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
This page
|
1,826,234 | $18,262,340 | |
| 3 | ZTS |
Zoetis Inc.
|
252,429 | $18,139,545 | |
| 4 | VTRS |
Viatris Inc
|
924,858 | $14,686,743 | |
| 5 | TAK |
Takeda Pharmaceutical Co Ltd
|
722,863 | $11,587,493 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
317,401 | $7,811,236 | |
| 7 | HROW |
Harrow, Inc.
|
180,893 | $7,682,525 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
|
198,546 | $6,726,737 |
All Filings in BCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18,262,340 | 1,826,234 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $17,375,751 | 1,825,184 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $14,231,232 | 1,824,517 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $13,836,508 | 1,822,992 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $16,336,659 | 1,823,288 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,777,342 | 1,836,979 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $13,859,254 | 1,842,986 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $14,008,996 | 1,843,289 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $11,393,768 | 1,843,652 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $9,367,193 | 1,843,936 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $11,045,889 | 1,844,055 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $13,055,653 | 1,844,019 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $12,985,659 | 1,844,554 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $15,379,577 | 1,844,074 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $21,169,969 | 1,844,074 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $23,261,792 | 1,846,174 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $19,573,253 | 1,850,024 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $30,086,560 | 1,850,342 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,615,907 | 1,849,524 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $26,589,586 | 1,850,354 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $29,254,096 | 1,850,354 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $18,818,100 | 1,850,354 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $15,213,637 | 2,042,099 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $7,024,820 | 2,042,099 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $9,720,391 | 2,042,099 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $4,182,538 | 2,091,269 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||